515 filings
Page 7 of 26
8-K
9s8l6ha
16 Jan 18
Geoffrey B. Davis Joins GT Biopharma’s Board of Directors
12:00am
SC 13G
lsizz4a660pk8v8io
4 Dec 17
GT Biopharma, Inc.
12:00am
4
1j8u9 sz8f
1 Dec 17
GT Biopharma / Steven W Weldon ownership change
12:00am
4
aqvhat4 f1xpaeh9let4
1 Dec 17
GT Biopharma / Tony Cataldo ownership change
12:00am
3
wlc ca155qmoj5pi
1 Dec 17
GT Biopharma / Raymond W. Urbanski ownership change
12:00am
3
n6kc wvbsk5kg
1 Dec 17
GT Biopharma / Mark J Silverman ownership change
12:00am
3
s6dun
1 Dec 17
GT Biopharma / Kathleen Clarence-Smith ownership change
12:00am
8-K
cqqzn5t poqulxwb9
16 Nov 17
Departure of Directors or Certain Officers
12:00am
SC 13G
fgrip
14 Nov 17
GT Biopharma, Inc.
12:00am
8-K
pprk7t55orllrj
12 Oct 17
GT Biopharma Announces Stock Sales Agreement with Holders of Converted Securities
12:00am
SC 13G/A
uoec4s9zwk5qjk3aajr
10 Oct 17
GT Biopharma, Inc.
12:00am
SC 13G/A
y2wip 6qtj512y1xn
20 Sep 17
GT Biopharma, Inc.
12:00am
D
sahfii oz
14 Sep 17
$4.54M in equity / debt, sold $4.54M, 9 investors
12:00am
8-K
lsxd48n j1sb4l
5 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
uocha
25 Jul 17
Amendments to Articles of Incorporation or Bylaws
12:00am
RW
2iyeg47c2vf6qitsf
24 Jul 17
Registration withdrawal request
12:00am
8-K
2llsxyxzph
26 Jun 17
Oxis Agrees to Acquire Georgetown Translational Pharmaceuticals, Appoints New Chief Executive Officer and Chief Medical Officer
12:00am
DEF 14C
kkhpw ymnkbtq
12 May 17
Information statement
12:00am